Institutions own 18% of NewAmsterdam Pharma Company N.V. (NASDAQ:NAMS) shares but private equity firms control 52% of the company
Key Insights NewAmsterdam Pharma's significant private equity firms ownership suggests that the key decisions are...
Newamsterdam Pharma Michael Davidson Newamsterdam Pharma Company Frazier Life Sciences Management Company Ownership Life Sciences Management
Source: yahoo.com